← Back to Search

Other

Low Glycemic Index Diet Group for Epilepsy

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of focal or generalized epilepsy as defined by the International League Against Epilepsy
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the intervention until 3 months postpartum
Awards & highlights

Study Summary

This trial studies how a low glycemic diet affects pregnant people with epilepsy, examining how it affects their seizures, tolerance, and gut bacteria.

Who is the study for?
This trial is for pregnant individuals with epilepsy. Participants will be following a low glycemic index diet and providing stool and blood samples up to three times during the study. The trial excludes those not willing to adhere to the dietary plan or unable to provide samples as required.Check my eligibility
What is being tested?
Researchers are testing if a low glycemic index diet is tolerable, can change seizure frequency, and affect gut bacteria in pregnant people with epilepsy. They'll compare results from participants on this diet against those who aren't following any structured diet plan.See study design
What are the potential side effects?
Potential side effects of a low glycemic index diet may include changes in bowel habits, such as constipation or diarrhea, possible nutrient deficiencies if not properly managed, and hypoglycemia (low blood sugar levels).

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with epilepsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the intervention until 3 months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the intervention until 3 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tolerability of the low glycemic index diet in pregnant people with epilepsy
Secondary outcome measures
Gut Bacteria Composition
Metabolic pathway alterations
Seizure Frequency

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Low Glycemic Index Diet GroupExperimental Treatment1 Intervention
A low glycemic index diet will be started with ongoing dietician support & food questionnaires until pregnancy completion.
Group II: Standard Diet GroupActive Control1 Intervention
A standard diet, as chosen by participants, will be followed with ongoing food questionnaires until pregnancy completion.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,609 Previous Clinical Trials
11,470,306 Total Patients Enrolled
11 Trials studying Epilepsy
54,292 Patients Enrolled for Epilepsy
Epilepsy FoundationOTHER
10 Previous Clinical Trials
394 Total Patients Enrolled
8 Trials studying Epilepsy
351 Patients Enrolled for Epilepsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is this clinical investigation open?

"To participate in this study, individuals must be between 18 and 45 years of age and have been diagnosed with epilepsy. There are currently 21 slots open for recruitment."

Answered by AI

Are seniors eligible to enroll in this investigation?

"To be eligible for inclusion in this medical trial, applicants must between the ages of 18 and 45."

Answered by AI

Are there any openings available for participation in this experiment?

"According to the information on clinicaltrials.gov, recruitment for this trial has been terminated as of December 14th 2023. However, there are currently 239 other trials that are actively seeking participants."

Answered by AI
~14 spots leftby Nov 2025